ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Sanofi And Lonza Detail Job Cuts

by Rick Mullin
September 20, 2010 | APPEARED IN VOLUME 88, ISSUE 38

As part of an R&D restructuring program announced last year, Sanofi-Aventis will close its research facility in the Great Valley region of Pennsylvania within the next year, eliminating 400 jobs. The 57 employees in the company’s clinical-supply-related business in Great Valley will not be affected, and the company says it is offering 303 employees relocation options. Meanwhile, Lonza reported to the Pennsylvania Department of Labor this month that it will eliminate 106 jobs at its Conshohocken active pharmaceutical ingredients facility, which it announced last January that it would close. The firm has said that its Shawinigan, Quebec, and Wokingham, England, facilities would also be affected by a company-wide program that targets 175 jobs (C&EN, Jan. 18, page 16).

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment